ROLE OF NUCLEAR FACTOR (NF)-kB PROTEIN IN ATHEROSCLEROSIS AND DIABETES: A POTENTIAL THERAPEUTIC TARGET

Authors

  • Dolzhenko A. Biomedical Research Unit, Institute Molecular Medicine Martin-Luther University Halle-Wittenberg, Germany
  • Richter T. Department of Cardiology Clinic Median, Bad Lausick, Germany
  • Sagalovsky S. Department of Cardiology Clinic Median, Bad Lausick, Germany

DOI:

https://doi.org/10.21856/j-PEP.2015.4.11

Keywords:

atherosclerosis, diabetes, nuclear factor (NF)-kB protein, inflammation, therapeutic target

Abstract

Cardiovascular diseases and diabetes are the leading cause of morbidity and mortality in all countries. Atherosclerosis, the background for many cardiovascular diseases, is characterized by the accumulation of lipid and fibrotic entities in large arteries and bears many similarities with chronic inflammatory diseases such as diabetes. Common features include extravasation of blood-derived leukocytes, as well as production of cytokines, chemokines and matrix-degrading enzymes. There are also many shared signaling pathways, including activation of the nuclear factor kB (NF-kB) cascade. In the pathology of atherosclerosis and diabetes NF-kB is essential to the cross-talk between cytokines, adhesion molecules and growth factors, leading to atherosclerotic plaque formation, growth and eventual rupture. The intent of this paper is to gather and summarize information on the role of NF-kB in the pathology of atherosclerosis and diabetes. Thus, it is essential to understand the role of this important signaling cascade in atherosclerosis and diabetes, in a quest for more specific therapeutic targets.

References

Sarah JG, Johanson J. Atherosclerosis: molecular and cellular mechanisms, Weinheim, 2010: 398 p.

Sarah JG, Cressida L. Atherosclerosis: molecular and cellular mechanisms, Weinheim, 2010: 3-20.

Oeckinghaus A, Ghosh S. Cold Spring Harb Perspect Biol 2009; 1(4):a34.

Asano S, Fukuda Y, Beck F, et al. Science 2015;347:439-442.

Li ZW, Karin M. NF-kB/Rel transcription factor family, N.Y. Springer Sci 2006:12-25.

Israel A. Cold Spring Harb Perspect Biol 2010;2(3):a158.

Lee SH, Toth Z, Wong LY, et al. Clin Miciobiol Portal 2012; 3(6):e411-412.

Kray AE, Carter RS, Pennington KN, et al. J Biol Chem 2005; 280(43):35974-35982.

Hoesel B, Schmid JA. Mol Cancer 2013; 12:86-92.

Zamanian-Daryoush M, Mogensen TH, DiDonato JA, et al. Mol Cell Biol 2000; 20(4):1278-1290.

Adli M, Merkhofer E,Cogswell P. PLoS One 2010;5(2):e9428.

Sun SC. Cell Res 2011; 21(1):71-85.

Andreakos E, Smith C, Kiriakidis S, et al. Arthritis Rheum 2003; 48(7):1901-1912.

Li Q,Verma IM. Nat Rev Immunol 2002; 2(10):725-734.

Solt LA, Madge LA, May MJ. J Biol Chem 2009;284(40):27596-27608.

Roman-Blas JA, Jimenez SA. Osteoarthritis Cartilage 2006; 14(9):839-848.

Karin M. Ann Rheum Dis 2004; 63(2):i62-i64.

Kempe S, Kestler H, Lasar A, Wirth T. Nucleic Acids Res 2005; 33(16):5308-5319.

Ley K. Adhesion molecules: function and inhibition, Basel, 2007: 161 p.

Oeckinghaus A, Hayden MS, Ghosh S. Nature Immunol 2011; 12(8):695-708.

De Winther MPJ, Kanters E, Kraal G, Hofker MH. Atheroscler Thromb Vasc Biol 2005; 25:904-914.

Wilson SH, Best PJ, Edwards WD, et al. Atherosclerosis 2002; 160(1):147-153.

Bu DX, Johansson ME, Ren J, et al. Atheroscler Thromb Vasc Biol 2010; 30(12):2604-2610.

Gareus R, Kotsaki E, Xanthoulea S, et al. Cell Metab 2008; 8:372-383.

Kanters E, Pasparakis M, Gijbels MJ, et al. J Clin Invest 2003; 112(8):1176-1185.

Lion HC. NF-kB/Rel transcription factor family, N.Y. Springer Sci, 2006: 185 p.

Ferreira V, Van Dijk KW, Groen AK, et al. Atherosclerosis 2007; 192(2):283-290.

Sage AP, Tintut Y, Demer LL. Nat Rev Cardiol 2010; 7(9):528-536.

Breuss JM, Cejna M, Bergmeister H, et al. Circulation 2002; 105(5):633-638.

Gupta SC, Sundaram C, Reuter S, Aggrawal BB. Biochem Biophys Acta 2010; 1799(10-12):775-787.

Ji KT, Qian L, Nan JL, et al. Clinical Chem 2008;54(1):24-38.

Cominacini L, Anselmi M, Garbin U, et al. J Am. Coll Cardiol 2005; 46(5):799-806.

Garelnabi M, Kakumanu S, Litvinov D. Oxidative stress and diseases, Croatia, 2012: 199-240.

Chappel SJ, Cheng X, Mann GE. Redox Biol 2013;1(1):319-331.

Tehlivets O. J Lipids 2011; 2011:1-12.

Den Dekker MAM, Zwiers M, Van der Heuvel ER, et al. PloS One 2013; 8(12):e83084.

Satta N, Kruithof EKO, Fickentscher C, et al. Blood 2011; 117(20):5523-5531.

Park JE, Kim YI, Yi AK. J Immunol 2009;182(10):6316-6327

Lawrence T. Cold Spring Harb Perspect Biol 2009;1(6):a001651

Kim TW, Febbraio M, Robinet P, et al. J Immunol 2011; 186(5):2871-2880.

Verstak B, Nagpai K, Bottomley SP, et al. J Biol Chem 2009; 284(36):24192-24203.

Xu S, Zhi H, Hou X, Jiang B. Biochem Biophys Res Commun 2011; 410(3):543-548.

Mallat Z, Taleb S, Ait-Oufella H, Tedyui A. J Lipid Res 2009; 50(Suppl):S364-S369.

Brasier A. Cardiovasc Res 2010; 86(2):211-218.

Matsushita N, Endo Y, Sato K, et al. PLoS One 2011; 6(8):e23324

Gilmore T, Mosialos G. Nuclear factor — kB: regulation and role in disease, Dortrecht, 2003: 89-114.

Niessner A, Weyand CM. Clin Immunol 2011;134(1):25.

Zernecke A. Atheroscler Thromb Vascul Biol 2015;35(4):763-770.

Moore KJ, Sheedy FJ, Fisher EA. Nat Rev Immunol 2013; 13(10):709-721.

Saraiva M, O’Garra A. Nat Rev Immunol 2010;10(3):170-181.

Chistiakov DA, Orekhov AN, Bobryshev YV. Acta Physiol 2015; 214(1):33-50.

Gilmore TD, Herscovitch M. Oncogene 2006;25(51):6887-6899.

Tang JR, Michaelis KA, Nozik-Grayck E, et al. J Immunol 2013; 190(6):4049.

Koprowska K, Czyz M. Postepy Hig Med Dosw 2010;64(1):100-114

Tas SW, Vervoordeldonk MJBM, Tak PP. Curr Gene Ther 2009; 9(3):160-170.

Trask OJ. Nuclear factor kappa B (NF-kB) translocation, Bethesda, MD, 2012: 1-22.

Amschler K, Schön MP, Pletz N, et al. J Invest Dermatol 2010; 130(4):1073-1086.

Ahn KS, Sethi G, Chao TH, et al. Blood 2007;110(7):2286-2295.

Zhang LL, Li Y, Wang Y, et al. PLoS ONE 2015;42(2):339-345.

Yoon JW, Kang JK, Lee KR, et al. J Toxicol Environ Health A 2005; 68(23-24):2005-2017.

Saadone A, Masters S, DiDonato J, et al. AJ Respir Cell Mol Biol 2007; 36(6):728-736.

Xu X, Steere RR, Fedorchuk CA, et al. PLoS ONE 2011; 6(11):e28216.

Hölschermann H, Schuster D, Parviz B, et al. Atherosclerosis 2006; 185(2):240-245.

Chansrichavala P, Chantharaksri U, Sritara P, Chaiyaroj S. Asian Pacific J Allergy Immunol 2009;27(1):49-57.

Marchesi C, Paradis P, Schiffrin EL. Trends Pharmacol Sci 2008; 29(7):367-374.

Mladenova D, Pangon L, Currey N, et al. Cell Commun Signal 2013; 11(1):73-84.

Du S, Hiramatsu N, Hayakawa H, et al. J Immunol 2009; 182(11):7201-7211.

Sagalovsky S, Richter T. Int Med J 2012; 18(4):71-78.

Helas S, Goettsch C, Schoppet M, et al. Am J Pathol 2009; 175(2):473-478.

Lerman DA, Mackenzie NCW, Zhu D, et al. Eur Heart J 2012; 33(1):1049-1049.

Downloads

Published

2015-12-03

How to Cite

Dolzhenko, A., Richter, T., & Sagalovsky, S. (2015). ROLE OF NUCLEAR FACTOR (NF)-kB PROTEIN IN ATHEROSCLEROSIS AND DIABETES: A POTENTIAL THERAPEUTIC TARGET. Problems of Endocrine Pathology, 54(4), 87-104. https://doi.org/10.21856/j-PEP.2015.4.11